Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 100.
255. lappuse
... milligrams every 6 to 8 hours , not to exceed 18.75 milligrams in 24 hours . ( g ) For products containing chlorpheniramine maleate identified in $ 341.12 ( c ) . Children 2 to under 6 years of age : oral dosage is 1 milligram every 4 ...
... milligrams every 6 to 8 hours , not to exceed 18.75 milligrams in 24 hours . ( g ) For products containing chlorpheniramine maleate identified in $ 341.12 ( c ) . Children 2 to under 6 years of age : oral dosage is 1 milligram every 4 ...
276. lappuse
... milligrams . 25 to 37 pounds 38 to 62 pounds 250 milligrams . 63 to 87 pounds 375 milligrams . 88 to 112 pounds 500 milligrams . 113 to 137 pounds 625 milligrams . 750 milligrams . 138 to 162 pounds 163 to 187 pounds 188 pounds and over 875 ...
... milligrams . 25 to 37 pounds 38 to 62 pounds 250 milligrams . 63 to 87 pounds 375 milligrams . 88 to 112 pounds 500 milligrams . 113 to 137 pounds 625 milligrams . 750 milligrams . 138 to 162 pounds 163 to 187 pounds 188 pounds and over 875 ...
390. lappuse
... milligrams of tetra- cycline hydrochloride working stand- ard into a suitable - sized volumetric flask . Dissolve ... milligrams of drug dissolved ; Au - Absorbance of sample ; c - Concentration of standard in milligrams ; d - Dilution ...
... milligrams of tetra- cycline hydrochloride working stand- ard into a suitable - sized volumetric flask . Dissolve ... milligrams of drug dissolved ; Au - Absorbance of sample ; c - Concentration of standard in milligrams ; d - Dilution ...
394. lappuse
... milligrams per milliliter ; and d = Dilution factor of the sample filtrate . ( 16 ) Loracarbef— ( i ) Preparation of the working standard solution . Accurately weigh approximately 110 milligrams of the loracarbef working standard into a ...
... milligrams per milliliter ; and d = Dilution factor of the sample filtrate . ( 16 ) Loracarbef— ( i ) Preparation of the working standard solution . Accurately weigh approximately 110 milligrams of the loracarbef working standard into a ...
422. lappuse
... milligrams of sample with distilled water to obtain a con- centration of 0.5 milligram per milli- liter ( estimated ) ... milligrams ; W = Weight of the moxalactam working standard in milligrams ; P = Potency of the moxalactam working ...
... milligrams of sample with distilled water to obtain a con- centration of 0.5 milligram per milli- liter ( estimated ) ... milligrams ; W = Weight of the moxalactam working standard in milligrams ; P = Potency of the moxalactam working ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning